No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
LLY250117P850000
- 55.33
- -8.67-13.55%
15min DelayClose Jan 10 16:00 ET
60.50High55.33Low
60.50Open64.00Pre Close3 Volume146 Open Interest850.00Strike Price17.63KTurnover43.66%IV0.65%PremiumJan 17, 2025Expiry Date50.10Intrinsic Value100Multiplier4DDays to Expiry5.23Extrinsic Value100Contract SizeAmericanOptions Type-0.8939Delta0.0050Gamma15.47Leverage Ratio-0.6913Theta-0.0689Rho-13.83Eff Leverage0.1600Vega
Intraday
- 5D
- Daily
News
Express News | Eli Lilly Sues Thrive Health and Wellness LLC & Valhalla Vitality LLC for Sale of Unapproved Tirzepatide Products- Court Filing
AI Trader Outperformed in 2024. Nvidia, Tesla, and Broadcom Are Some of Its Favorites.
Market Chatter: Eli Lilly Eyes $2.5 Billion Deal for Scorpion Therapeutics
Eli Lilly (NYSE:LLY) Shareholders Have Earned a 44% CAGR Over the Last Five Years
Can 2025 J.P. Morgan Healthcare Conference Spark Biotech M&A?
Key Deals This Week: FuboTV - Disney, Constellation Energy, Eli Lilly, Phillips 66, Intercontinental Exchange and More